Daniel Hutcheson, PhD, Chief Scientific Officer, will attend the Hanson and Wade GLP-1 Based Therapeutics Summit in Boston, MA, USA between April 14-16, 2026.
Have a model or indication in mind?
Speak to a researcherDaniel Hutcheson, PhD, Chief Scientific Officer, will attend the Hanson and Wade GLP-1 Based Therapeutics Summit in Boston, MA, USA between April 14-16, 2026.
Have a model or indication in mind?
Speak to a researcher